MicroRNA 5704 (MIR5704)

MicroRNA 5704 is a member of the microRNA (miRNA) family, which consists of small (~22-nucleotide) non-coding RNAs found in eukaryotes[1][5]. miRNAs are critical regulators of gene expression, typically acting via sequence-specific binding to mRNA transcripts and either repressing translation or promoting mRNA degradation[1][4][5]. They play roles in diverse cellular processes, including cell proliferation, differentiation, apoptosis, and development, and are frequently investigated as disease biomarkers and regulators in cancer, cardiovascular disease, inflammation, and other pathologies[1][3][4][5]. Despite extensive research into many miRNAs, as of the current date, there is no published evidence on the specific biological functions, disease associations, or therapeutic relevance of MIR5704. It is listed in miRNA sequence databases, but there are no curated studies or clinical applications tied directly to MIR5704. Currently, it is not considered a validated therapeutic target, receptor, enzyme, or transporter, and information is largely missing regarding its molecular interactions, disease linkage, or biomarker utility. The repetition of "hsa-mir-5704" alias is likely due to alternative naming conventions in miRNA databases, not due to misnaming, but this miRNA lacks sufficient contextual characterization to be considered a canonical drug target. Note: - MIR5704 is not a recognized therapeutic target according to current evidence (as of September 2025). - Specific functional or disease-related data for MIR5704 are absent, so entries for interacting drugs, mechanism of action, and safety concerns are set to null. - The is_incorrect flag is set to true due to the absence of sufficient functional/disease/target data for this molecule, although the name itself is not a misspelling. - The classification and functions provided are general for miRNAs, not MIR5704-specific, due to lack of available literature[1][3][4][5].

Other names

hsa-miR-5704MIR5704microRNA 5704